Compile Data Set for Download or QSAR
Report error Found 139 of affinity data for UniProtKB/TrEMBL: P03420
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554856(CHEMBL4740044)
Affinity DataEC50:  0.270nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554858(CHEMBL4750881)
Affinity DataEC50:  0.330nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572440(CHEMBL4469438)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554876(CHEMBL4747540)
Affinity DataEC50:  0.470nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572444(CHEMBL4878302)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554877(CHEMBL4755451)
Affinity DataEC50:  0.640nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572466(CHEMBL4876200)
Affinity DataIC50: 0.690nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572442(CHEMBL4872095)
Affinity DataIC50: 0.700nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554856(CHEMBL4740044)
Affinity DataEC50:  0.700nMAssay Description:Inhibition of F protein D486N mutant in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554874(CHEMBL4746199)
Affinity DataEC50:  0.740nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554875(CHEMBL4765002)
Affinity DataEC50:  0.770nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554864(CHEMBL4747375)
Affinity DataEC50:  0.810nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554859(CHEMBL4747256)
Affinity DataEC50:  0.870nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572463(CHEMBL4871101)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572464(CHEMBL4858040)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572450(Sisunatovir | Rv-521 | Rv521)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572451(CHEMBL4867108)
Affinity DataIC50: 1nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554873(CHEMBL4752524)
Affinity DataEC50:  1.10nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554872(CHEMBL4751254)
Affinity DataEC50:  1.10nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572465(CHEMBL4858949)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of Respiratory syncytial virus fusion proteinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572445(CHEMBL4865906)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572453(CHEMBL4874709)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572447(CHEMBL4860271)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554867(CHEMBL4752460)
Affinity DataEC50:  1.40nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554866(CHEMBL4753413)
Affinity DataEC50:  1.40nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572449(CHEMBL4853602)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554860(CHEMBL4757367)
Affinity DataEC50:  1.70nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50541848(CHEMBL4640616)
Affinity DataEC50:  2nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554861(CHEMBL4779491)
Affinity DataEC50:  2.10nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554870(CHEMBL4742185)
Affinity DataEC50:  2.5nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572448(CHEMBL4863172)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572452(CHEMBL4873528)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554863(CHEMBL4741045)
Affinity DataEC50:  2.70nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572454(CHEMBL4855358)
Affinity DataIC50: 3nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554858(CHEMBL4750881)
Affinity DataEC50:  3.10nMAssay Description:Inhibition of F protein D486N mutant in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572443(CHEMBL4872263)
Affinity DataIC50: 4.5nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554865(CHEMBL4761881)
Affinity DataEC50:  4.60nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572462(CHEMBL4876843)
Affinity DataIC50: 6.20nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554862(CHEMBL4758615)
Affinity DataEC50:  7nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50541848(CHEMBL4640616)
Affinity DataEC50:  8.10nMAssay Description:Inhibition of Human respiratory syncytial virus Fusion protein D486N mutant expressed in Hep2 cells assessed as reduction in virus-induced cytopathic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534230(WO2022081973, Example 34 | ((2R,3S,4R,5R)-5-(4-ami...)
Affinity DataEC50:  11nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022081973

TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50572441(CHEMBL4862291)
Affinity DataIC50: 11nMAssay Description:Inhibition of Respiratory syncytial virus A2 fusion protein expressed in HEK293T cells harboring GAL4-NF-kappaB assessed as reduction in cell-cell fu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534252(WO2022081973, Example 56 | ((2R,3S,4R,5R)-5-(4-ami...)
Affinity DataEC50:  13nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022081973

TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534244(WO2022081973, Example 48 | ((2R,3S,4R,5R)-5-(4-ami...)
Affinity DataEC50:  17nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022081973

TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554857(CHEMBL4752948)
Affinity DataEC50:  17nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554871(CHEMBL4756466)
Affinity DataEC50:  17nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534248(WO2022081973, Example 52)
Affinity DataEC50:  17nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022081973

TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534272(WO2022081973, Example 75 | ((2R,3S,4R,5R)-5-(4-ami...)
Affinity DataEC50:  17nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022081973

TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554869(CHEMBL4782630)
Affinity DataEC50:  21nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534245(WO2022081973, Example 49 | ((2R,3S,4R,5R)-5-(4-ami...)
Affinity DataEC50:  23nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2022
Entry Details
WIPO WO2022081973

Displayed 1 to 50 (of 139 total ) | Next | Last >>
Jump to: